Omeros Corporation

Omeros Corporationverified

OMER

Price:

$11.03

Market Cap:

$781.96M

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS); and Phase II clinical trial to treat COVID-19. Its clinical programs...[Read more]

Industry

Biotechnology

IPO Date

2009-10-08

Stock Exchange

NASDAQ

Ticker

OMER

The Enterprise Value as of December 2025 (TTM) for Omeros Corporation (OMER) is 883.69M

According to Omeros Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 883.69M. This represents a change of 61.64% compared to the average of 546.70M of the last 4 quarters.

Omeros Corporation (OMER) Historical Enterprise Value (quarterly & annually)

How has OMER Enterprise Value performed in the past?

The mean historical Enterprise Value of Omeros Corporation over the last ten years is 679.92M. The current 883.69M Enterprise Value has changed 12.90% with respect to the historical average. Over the past ten years (40 quarters), OMER's Enterprise Value was at its highest in in the March 2021 quarter at 1.44B. The Enterprise Value was at its lowest in in the June 2025 quarter at 358.18M.

Quarterly (TTM)
Annual

Average

679.92M

Median

667.35M

Minimum

472.80M

Maximum

966.04M

Omeros Corporation (OMER) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Omeros Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 101.80%

Maximum Annual Enterprise Value = 966.04M

Minimum Annual Increase = -28.91%

Minimum Annual Enterprise Value = 472.80M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024778.35M39.08%
2023559.64M18.37%
2022472.80M-27.03%
2021647.90M-22.79%
2020839.11M14.86%
2019730.52M6.37%
2018686.80M-28.91%
2017966.04M101.80%
2016478.71M-25.12%
2015639.30M-25.31%

Omeros Corporation (OMER) Average Enterprise Value

How has OMER Enterprise Value performed in the past?

The current Enterprise Value of Omeros Corporation (OMER) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

603.59M

5-year avg

659.56M

10-year avg

679.92M

Omeros Corporation (OMER) Enterprise Value vs. Peers

How is OMER’s Enterprise Value compared to its peers?

Omeros Corporation’s Enterprise Value is greater than ADC Therapeutics S.A. (262.56M), greater than Neumora Therapeutics, Inc. Common Stock (251.41M), greater than Lexicon Pharmaceuticals, Inc. (556.11M), greater than RAPT Therapeutics, Inc. (534.71M), greater than Bicycle Therapeutics plc (-152624053.00), greater than 4D Molecular Therapeutics, Inc. (496.31M), greater than KalVista Pharmaceuticals, Inc. (710.80M), greater than Fulcrum Therapeutics, Inc. (433.95M), less than Gossamer Bio, Inc. (930.39M), greater than Ocugen, Inc. (393.09M),

Build a custom stock screener for Omeros Corporation (OMER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omeros Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Omeros Corporation (OMER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Omeros Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Omeros Corporation's Enterprise Value?

What is the highest Enterprise Value for Omeros Corporation (OMER)?

What is the 3-year average Enterprise Value for Omeros Corporation (OMER)?

What is the 5-year average Enterprise Value for Omeros Corporation (OMER)?

How does the current Enterprise Value for Omeros Corporation (OMER) compare to its historical average?